21 Results for "

PPARG

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "PPARG" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-153344
CAS No.: 2924573-90-8
Purity:  99.79%
Target:  

PPAR

Research Areas:  

Cancer

FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. FX-909 can be used for the research of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80436

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-153364
CAS No.: 2829349-96-2
Purity:  98.68%
Target:  

PPAR

Research Areas:  

Cancer

FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models .
loading...
    loading...
Cat. No.: HY-W009066
CAS No.: 1241-94-7
Synonyms: EHDPP; Octicizer
2-Ethylhexyl diphenyl phosphate is an organophosphate flame retardants (OPFRs) and a PPARG agonist (EC20: 2.04 µM). 2-Ethylhexyl diphenyl phosphate also inhibits ERRγ transcriptional activity (IC50: 1.3 µM). 2-Ethylhexyl diphenyl phosphate upregulates 3β-HSD1, human chorionic gonadotropin (hCG) and progesterone secretion. 2-Ethylhexyl diphenyl phosphate can be used in studies of female reproduction and fetal development .
loading...
    loading...
Cat. No.: HY-108569
CAS No.: 118414-59-8
Purity:  ≥98.0%
Target:  

Antibiotic Bacterial PPAR

Research Areas:  

Infection

nTZDpa is an antibiotic. nTZDpa is a PPARG partial agonist. nTZDpa has antibacterial activity. nTZDpa is effective against growing and persistent Staphylococcus aureus by lipid bilayer disruption .
loading...
    loading...
Cat. No.: HY-RS10925
Research Areas:  

Others

PPARG Human Pre-designed siRNA Set A contains three designed siRNAs for PPARG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS10926
Research Areas:  

Others

Pparg Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pparg gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-160160
CAS No.: 2891706-79-7
Target:  

PPAR

Research Areas:  

Cancer

BAY-5516 is a inverse-agonist o PPARG, with the IC50 value of 6.1±3.6 nM that has anti-tumor effect .
loading...
    loading...
Cat. No.: HY-178447
PPARγ agonist 20 is a potent, orally active PPAR-γ agonist. PPARγ agonist 20 effectively increases antioxidant defenses (SOD, GSH) and reduces lipid peroxidation. PPARγ agonist 20 can upregulate of Pparg, Glut4, and AdipoQ, suppresses of TNF-α, IL-6, and NF-κB p65. PPARγ agonist 20 significantly lowers fasting blood glucose, improving glucose tolerance, and restoring metabolic balance in Streptozotocin (HY-13753)-Nicotinamide (HY-B0150)-induced diabetic rats. PPARγ agonist 20 can be used for the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-RS10927
Research Areas:  

Others

Pparg Rat Pre-designed siRNA Set A contains three designed siRNAs for Pparg gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-160161
CAS No.: 2891706-78-6
Target:  

PPAR

Research Areas:  

Cancer

BAY-5094 is a PPAR gamma (PPARG) inverse agonist. BAY-5094 has oral activity. BAY-5094 can be used in the research of luminal bladder cancer .
loading...
    loading...
Cat. No.: HY-160159
CAS No.: 1415321-54-8
Target:  

PPAR

Research Areas:  

Metabolic Disease

Anticancer agent 183 (example 48) is a non-agonistic PPARG modulator. Anticancer agent 183 has a high affinity to PPARG (PPARγ). Anticancer agent 183 inhibits kinase-mediated phosphorylation of PPARG. Anticancer agent 183 can used for research on metabolic diseases to avoid side effects .
loading...
    loading...
Cat. No.: HY-160188
CAS No.: 2891706-83-3
Target:  

PPAR

Research Areas:  

Cancer

BAY-9683 is an orally active covalent PPARG inverse agonist. BAY-9683 can be used in the study of diseases with overactive PPARG, such as luminal bladder cancer .
loading...
    loading...
Cat. No.: HY-121579
CAS No.: 227002-04-2
Target:  

PPAR

Research Areas:  

Others

L-764406 is a non-thiazolidinedione (TZD)-type PPARg nuclear receptor ligand with high affinity. L-764406 has significant binding ability to PPARg (IC50=70 nM). L-764406 exhibited partial agonist activity and induced expression of the adipocyte-specific gene aP2 in chimeric receptors expressing the PPARg LBD and the corresponding reporter gene, as well as in 3T3-L1 cells. In contrast, L-764406 showed no activity in cells transfected with chimeric receptors containing PPARa or PPARd LBDs .
loading...
    loading...
Cat. No.: HY-P73701
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CIMT1; GLM1; NR1C31; PPARG2; PPARG5; PPARGamma; PPARG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701336
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PPARG; Peroxisome proliferator-activated receptor gamma; PPAR-gamma; Nuclear receptor subfamily 1 group C member 3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P85457
Synonyms: PPARG; NR1C3; Peroxisome proliferator-activated receptor gamma; PPAR-gamma; Nuclear receptor subfamily 1 group C member 3

Host:  

Mouse

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse, Rat, Bovine, Dog, Goat, Pig, Rabbit, Sheep

loading...
    loading...
Cat. No.: HY-P705437
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PPARG; Nr1c3; Peroxisome proliferator-activated receptor gamma; PPAR-gamma; Nuclear receptor subfamily 1 group C member 3
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P702572
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CIMT1, GLM1, NR1C31, PPARG2, PPARG5, PPARGamma, PPARG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P790012Y
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CIMT1; GLM1; NR1C31; PPARG2; PPARG5; PPARGamma; PPARG
Species:  
Source:  
loading...
    loading...